
RBC Venture Partners
Description
RBC Venture Partners serves as the strategic venture capital arm of the Royal Bank of Canada, operating under the umbrella of RBC Capital Markets. Based in Toronto, Canada, this entity is distinct from RBC's internal innovation lab, RBC Ventures, focusing instead on external investments in high-growth companies. Its primary mandate is to identify and invest in businesses that offer strategic relevance and potential synergy with RBC's extensive financial services operations, thereby extending the bank's reach and capabilities in emerging technological landscapes.
The firm primarily targets later-stage growth equity opportunities, typically participating in Series B, C, D, and subsequent funding rounds. Their investment thesis centers on sectors critical to the future of finance and enterprise, including financial technology (fintech), enterprise software, data analytics, and other innovative solutions that can enhance or disrupt traditional banking services. RBC Venture Partners seeks companies with proven business models, strong market traction, and clear pathways to scalability, often looking for opportunities to integrate these solutions within RBC's ecosystem or offer them to its vast client base.
RBC Venture Partners is known for participating in substantial funding rounds, reflecting its focus on mature growth companies. For instance, the firm participated in a $100 million Series D round for identity verification company Trulioo in 2021, and a $70 million Series D for Clearco (formerly Clearbanc) in 2020, a company specializing in non-dilutive capital for e-commerce businesses. Their strategic involvement often extends beyond capital, offering portfolio companies access to RBC's vast network, expertise, and potential for commercial partnerships.
Investor Profile
RBC Venture Partners has backed more than 45 startups, with 0 new investments in the last 12 months alone. The firm has led 10 rounds, about 22% of its total and boasts 31 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series C, Series B rounds (top funding stages).
- Majority of deals are located in United States, Canada, United Kingdom.
- Strong thematic focus on Enterprise Software, Software, Health Care.
- Typical check size: $5M – $25M.
Stage Focus
- Series Unknown (36%)
- Series C (22%)
- Series B (20%)
- Series A (11%)
- Series D (4%)
- Series F (4%)
- Debt Financing (2%)
Country Focus
- United States (60%)
- Canada (31%)
- United Kingdom (9%)
Industry Focus
- Enterprise Software
- Software
- Health Care
- Saas
- Information Technology
- Biotechnology
- Telecommunications
- Mobile
- Security
- Internet
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.